Down-regulation of RhoE is associated with progression and poor prognosis in hepatocellular carcinoma

Molecular signature of hepatocellular carcinoma, hope or hype in prognosis and therapy

(2011) Fei Chen   SEMINARS IN CANCER BIOLOGY

Rnd proteins: Multifunctional regulators of the cytoskeleton and cell cycle progression

(2010) Philippe Riou et al.   BIOESSAYS

Up-regulation of Tiam1 and Rac1 Correlates with Poor Prognosis in Hepatocellular Carcinoma

(2010) Wanyong Yang et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

(2010) Kentaroh Yamamoto et al.   JOURNAL OF GASTROENTEROLOGY

Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC

(2010) Masanori Matsuda et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Management of Hepatocellular Carcinoma: From Prevention to Molecular Targeted Therapy

(2010) Masatoshi Kudo   ONCOLOGY

The role of COX-2 in intestinal inflammation and colorectal cancer

(2009) D Wang et al.   ONCOGENE

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics

(2009) Mohamed IF Shariff et al.   Expert Review of Gastroenterology & Hepatology

Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients

(2008) Yi Ding et al.   INTERNATIONAL JOURNAL OF CANCER